Kinnari Patel, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,409 shares at $6.53 ($9K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
Open-market sale of $9k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2025-02-25 | $129K | — | Filing → |
| RCKT | SELL | 2024-11-25 | $120K | — | Filing → |
| RCKT | SELL | 2024-08-20 | $148K | — | Filing → |